{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:19:32Z","timestamp":1795058372421,"version":"4.10.2"},"reference-count":46,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>TP53-mutated myeloid malignancies are associated with complex cytogenetics and extensive structural variants, which complicates detailed genomic analysis by conventional clinical techniques. We performed whole-genome sequencing (WGS) of 42 acute myeloid leukemia (AML)\/myelodysplastic syndromes (MDS) cases with paired normal tissue to better characterize the genomic landscape of TP53-mutated AML\/MDS. WGS accurately determines TP53 allele status, a key prognostic factor, resulting in the reclassification of 12% of cases from monoallelic to multihit. Although aneuploidy and chromothripsis are shared with most TP53-mutated cancers, the specific chromosome abnormalities are distinct to each cancer type, suggesting a dependence on the tissue of origin. ETV6 expression is reduced in nearly all cases of TP53-mutated AML\/MDS, either through gene deletion or presumed epigenetic silencing. Within the AML cohort, mutations of NF1 are highly enriched, with deletions of 1 copy of NF1 present in 45% of cases and biallelic mutations in 17%. Telomere content is increased in TP53-mutated AMLs compared with other AML subtypes, and abnormal telomeric sequences were detected in the interstitial regions of chromosomes. These data highlight the unique features of TP53-mutated myeloid malignancies, including the high frequency of chromothripsis and structural variation, the frequent involvement of unique genes (including NF1 and ETV6) as cooperating events, and evidence for altered telomere maintenance.<\/jats:p>","DOI":"10.1182\/bloodadvances.2023010156","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T21:03:16Z","timestamp":1687294996000},"page":"4586-4598","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":32,"title":["Genomic landscape of <i>TP53<\/i>-mutated myeloid malignancies"],"prefix":"10.1182","volume":"7","author":[{"given":"Haley J.","family":"Abel","sequence":"first","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2846-8831","authenticated-orcid":false,"given":"Karolyn A.","family":"Oetjen","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4266-6700","authenticated-orcid":false,"given":"Christopher A.","family":"Miller","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4500-6583","authenticated-orcid":false,"given":"Sai M.","family":"Ramakrishnan","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4376-4663","authenticated-orcid":false,"given":"Ryan B.","family":"Day","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichole M.","family":"Helton","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2766-9551","authenticated-orcid":false,"given":"Catrina C.","family":"Fronick","sequence":"additional","affiliation":[{"name":"2McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Fulton","sequence":"additional","affiliation":[{"name":"2McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon E.","family":"Heath","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7970-702X","authenticated-orcid":false,"given":"Stefan P.","family":"Tarnawsky","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar","family":"Nonavinkere Srivatsan","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Duncavage","sequence":"additional","affiliation":[{"name":"3Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4389-043X","authenticated-orcid":false,"given":"Molly C.","family":"Schroeder","sequence":"additional","affiliation":[{"name":"3Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8832-3661","authenticated-orcid":false,"given":"Jacqueline E.","family":"Payton","sequence":"additional","affiliation":[{"name":"3Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5314-3043","authenticated-orcid":false,"given":"David H.","family":"Spencer","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"2McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"},{"name":"3Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Walter","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Westervelt","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"DiPersio","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Ley","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3170-7581","authenticated-orcid":false,"given":"Daniel C.","family":"Link","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"issue":"7","key":"2023082115140762900_bib1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"9","key":"2023082115140762900_bib2","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood-2011-08-375758","article-title":"TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome","volume":"119","author":"R\u00fccker","year":"2012","journal-title":"Blood"},{"issue":"11","key":"2023082115140762900_bib3","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"10","key":"2023082115140762900_bib4","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/s41591-020-1008-z","article-title":"Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes","volume":"26","author":"Bernard","year":"2020","journal-title":"Nat Med"},{"issue":"15","key":"2023082115140762900_bib5","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1182\/blood.2021014472","article-title":"Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome","volume":"139","author":"Grob","year":"2022","journal-title":"Blood"},{"issue":"9","key":"2023082115140762900_bib6","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/bloodadvances.2021006239","article-title":"TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS\/AML","volume":"6","author":"Weinberg","year":"2022","journal-title":"Blood Adv"},{"issue":"10","key":"2023082115140762900_bib7","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa2024534","article-title":"Genome sequencing as an alternative to cytogenetic analysis in myeloid cancers","volume":"384","author":"Duncavage","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"2023082115140762900_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(16)30626-X","article-title":"Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study","volume":"18","author":"Takahashi","year":"2017","journal-title":"Lancet Oncol"},{"issue":"1","key":"2023082115140762900_bib9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1470-2045(16)30627-1","article-title":"Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study","volume":"18","author":"Gillis","year":"2017","journal-title":"Lancet Oncol"},{"issue":"7540","key":"2023082115140762900_bib10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature13968","article-title":"Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia","volume":"518","author":"Wong","year":"2015","journal-title":"Nature"},{"key":"2023082115140762900_bib11","article-title":"Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM","author":"Li","year":"16  2013","journal-title":"arXiv"},{"issue":"3","key":"2023082115140762900_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"3","key":"2023082115140762900_bib13","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res"},{"issue":"8","key":"2023082115140762900_bib14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","article-title":"Strelka2: fast and accurate calling of germline and somatic variants","volume":"15","author":"Kim","year":"2018","journal-title":"Nat Methods"},{"key":"2023082115140762900_bib15","author":"Van der Auwera","year":"2020"},{"issue":"1","key":"2023082115140762900_bib16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13059-021-02423-x","article-title":"GRIDSS2: comprehensive characterisation of somatic structural variation using single breakend variants and structural variant phasing","volume":"22","author":"Cameron","year":"2021","journal-title":"Genome Biol"},{"issue":"7781","key":"2023082115140762900_bib17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41586-019-1689-y","article-title":"Pan-cancer whole-genome analyses of metastatic solid tumours","volume":"575","author":"Priestley","year":"2019","journal-title":"Nature"},{"issue":"4","key":"2023082115140762900_bib18","doi-asserted-by":"crossref","first-page":"100112","DOI":"10.1016\/j.xgen.2022.100112","article-title":"Unscrambling cancer genomes via integrated analysis of structural variation and copy number","volume":"2","author":"Shale","year":"2022","journal-title":"Cell Genom"},{"issue":"3","key":"2023082115140762900_bib19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41588-019-0576-7","article-title":"Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing","volume":"52","author":"Cort\u00e9s-Ciriano","year":"2020","journal-title":"Nat Genet"},{"issue":"1","key":"2023082115140762900_bib20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12859-019-2851-0","article-title":"TelomereHunter - in silico estimation of telomere content and composition from cancer genomes","volume":"20","author":"Feuerbach","year":"2019","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"2023082115140762900_bib21","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41467-019-13824-9","article-title":"Genomic footprints of activated telomere maintenance mechanisms in cancer","volume":"11","author":"Sieverling","year":"2020","journal-title":"Nat Commun"},{"issue":"22","key":"2023082115140762900_bib22","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"2023082115140762900_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.exphem.2022.04.002","article-title":"Recurrent transcriptional responses in AML and MDS patients treated with decitabine","volume":"111","author":"Upadhyay","year":"2022","journal-title":"Exp Hematol"},{"issue":"5449","key":"2023082115140762900_bib24","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1126\/science.286.5449.2528","article-title":"Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome","volume":"286","author":"Bell","year":"1999","journal-title":"Science"},{"issue":"7","key":"2023082115140762900_bib25","doi-asserted-by":"crossref","first-page":"EVIDoa2200008","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular International Prognostic Scoring System for myelodysplastic syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evidence"},{"issue":"7728","key":"2023082115140762900_bib26","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"issue":"7793","key":"2023082115140762900_bib27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-cancer analysis of whole genomes","volume":"578","author":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium","year":"2020","journal-title":"Nature"},{"issue":"1","key":"2023082115140762900_bib28","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.3324\/haematol.2017.180497","article-title":"Chromothripsis is linked to TP53 alteration, cell cycle impairment, and dismal outcome in acute myeloid leukemia with complex karyotype","volume":"103","author":"R\u00fccker","year":"2018","journal-title":"Haematologica"},{"issue":"6","key":"2023082115140762900_bib29","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.cell.2013.02.023","article-title":"Criteria for inference of chromothripsis in cancer genomes","volume":"152","author":"Korbel","year":"2013","journal-title":"Cell"},{"issue":"2","key":"2023082115140762900_bib30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/bjh.14666","article-title":"Telomere length is an independent prognostic marker in MDS but not in de novo AML","volume":"178","author":"Williams","year":"2017","journal-title":"Br J Haematol"},{"issue":"3","key":"2023082115140762900_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3343\/alm.2017.37.3.195","article-title":"Dysregulation of telomere lengths and telomerase activity in myelodysplastic syndrome","volume":"37","author":"Park","year":"2017","journal-title":"Ann Lab Med"},{"key":"2023082115140762900_bib32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.leukres.2016.07.013","article-title":"Telomere length and associations with somatic mutations and clinical outcomes in acute myeloid leukemia","volume":"49","author":"Watts","year":"2016","journal-title":"Leuk Res"},{"issue":"31","key":"2023082115140762900_bib33","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2016.66.9622","article-title":"Shorter remission telomere length predicts delayed neutrophil recovery after acute myeloid leukemia therapy: a report from the Children\u2019s Oncology Group","volume":"34","author":"Gerbing","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"2023082115140762900_bib34","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41467-019-13885-w","article-title":"High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat Commun"},{"issue":"17","key":"2023082115140762900_bib35","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1182\/blood-2016-12-754796","article-title":"Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation","volume":"129","author":"Yoshizato","year":"2017","journal-title":"Blood"},{"issue":"22","key":"2023082115140762900_bib36","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1182\/bloodadvances.2020003120","article-title":"Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia","volume":"4","author":"Short","year":"2020","journal-title":"Blood Adv"},{"issue":"2","key":"2023082115140762900_bib37","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cell.2018.02.037","article-title":"Profound tissue specificity in proliferation control underlies cancer drivers and aneuploidy patterns","volume":"173","author":"Sack","year":"2018","journal-title":"Cell"},{"issue":"3","key":"2023082115140762900_bib38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cell.2017.06.034","article-title":"Genome organization drives chromosome fragility","volume":"170","author":"Canela","year":"2017","journal-title":"Cell"},{"issue":"12","key":"2023082115140762900_bib39","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1038\/s41375-018-0147-4","article-title":"NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome","volume":"32","author":"Eisfeld","year":"2018","journal-title":"Leukemia"},{"issue":"16","key":"2023082115140762900_bib40","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1158\/1078-0432.CCR-09-2639","article-title":"NF1 inactivation in adult acute myelogenous leukemia","volume":"16","author":"Parkin","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2023082115140762900_bib41","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1182\/bloodadvances.2018028480","article-title":"Complex karyotype AML displays G2\/M signature and hypersensitivity to PLK1 inhibition","volume":"3","author":"Moison","year":"2019","journal-title":"Blood Adv"},{"issue":"24","key":"2023082115140762900_bib42","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1200\/JCO.2005.04.5450","article-title":"Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization","volume":"24","author":"R\u00fccker","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"2023082115140762900_bib43","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1186\/1471-2164-15-784","article-title":"Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype","volume":"15","author":"Feurstein","year":"2014","journal-title":"BMC Genomics"},{"issue":"10","key":"2023082115140762900_bib44","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.3324\/haematol.2014.104406","article-title":"ETV6 mutation in a cohort of 970 patients with hematologic malignancies","volume":"99","author":"Wang","year":"2014","journal-title":"Haematologica"},{"issue":"6274","key":"2023082115140762900_bib45","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/345458a0","article-title":"Telomeres shorten during ageing of human fibroblasts","volume":"345","author":"Harley","year":"1990","journal-title":"Nature"},{"issue":"suppl 1","key":"2023082115140762900_bib46","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood-2021-152567","article-title":"Mutant TP53 prevents telomere shortening in acute myeloid leukemia","volume":"138","author":"Wahida","year":"2021","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/16\/4586\/2072940\/blooda_adv-2023-010156-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/16\/4586\/2072940\/blooda_adv-2023-010156-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T15:14:28Z","timestamp":1692630868000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/16\/4586\/496429\/Genomic-landscape-of-TP53-mutated-myeloid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":46,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2023,8,22]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023010156","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]}}}